Contaminated Blood and Blood Products

Harriett Baldwin Excerpts

Thursday 14th October 2010 Commons Chamber

[Dr Lee]

Yes. If one does the division, one realises that one figure must be wrong—off the top of my head, the figure is 853 as opposed to 353. I encourage the hon. Gentleman to look at that point.

If the figure is £1 billion, we spend £1 billion on the NHS every three and a half days. We can find that money. I do not know how one prices a liver, and I do not know how one prices a liver transplant that does not happen. I cannot put a price on that, and I challenge anyone else to do so. We are talking about 4,670 people, so we can behave appropriately at last and provide the appropriate compensation.

On the financial implications, HIV widows are forced through the Benefits Agency to seek work within weeks of their partner’s death, and hepatitis C widows whose partners died before 2004 receive no financial help at all. The implications for the haemophilia community are stark. I cannot say that we should trim this and that because of the comprehensive spending review; I would rather we borrowed the £500 million and did the right thing.

[Harriett Baldwin (West Worcestershire) (Con)]

Given my hon. Friend’s medical background, will he explain whether it is appropriate for someone with hepatitis C to receive incapacity benefit?

[Dr Lee]

I believe that it is, but, with respect, that is missing the point. As far as I am concerned, the Department of Health is culpable. This is not a party political matter; it is a departmental matter. It had a series of opportunities over a number of years to deal with the issue, but it missed them, and surprisingly it lost a few documents in the process. That is shocking. If the Department is worried about precedent, that makes me concerned about other conditions and treatments. Is there something else that we should know about? If this is about precedent, I should like to set one: this was wrong and we should pay out appropriately.

--- Later in debate ---

[Harriett Baldwin (West Worcestershire) (Con)]

Thank you for allowing me to speak in this historic debate, Mr Deputy Speaker. Like so many of my colleagues, this issue has been brought to my attention by the impact it has had on the life of a constituent—in my case, the constituent is Colette Wintle.

Colette was born in 1959 and was diagnosed with haemophilia in 1962. When she went to have her tonsils out in 1976, she was given American blood products which first caused her infection with hepatitis. In 1982, at a hospital in Kent, she was given factor VIII concentrate, which infected her with hepatitis C. In 1985, at a hospital in London, she was once again given treatment with blood products, which made her very ill with hepatitis C, although mercifully she did not contract HIV. Subsequently, she has been so weak with illness that she had to stop work at the age of 38. She has contracted cirrhosis of the liver and lives in fear of developing liver cancer in her damaged liver.

As we all know, it is not possible for doctors to undo the damage to Colette’s health and it is not possible for her ever to be adequately compensated for the harm that was done to her by the infected blood products. The question is what we should do now, as a society, to compensate people such as Colette and her family. We have heard about the Skipton Fund, and I think that everyone in this debate acknowledges that the payments of a maximum of £45,000 are not adequate to compensate someone for that treatment.

We have also talked a lot about different numbers, and I wish to help the House. As 4,672 people have been infected over the years, a payment of £1 million to each of them would involve £4.672 billion. A payment of £100,000 to every sufferer would involve £467.2 million—I believe I have those figures right. That puts the £3 billion cost into context; it would work out to be £642,000 per individual. Colette has not been able to work since she was 38 and has had to pay for her NHS prescriptions. She looks ahead to the future, but her general practitioner is unable to assure her that she will have access to specialist nursing at home if her condition worsens.

I welcome what the Minister said in her statement and the fact that she will look urgently at a number of issues. However, will she clarify whether the compensation that will be recommended by the review will reflect the length of time that individuals have had to suffer and been unable to work because of the illness? Will the review also examine something that is being debated a lot with the Department for Work and Pensions: what happens when an individual is being assessed for their ability to work? Can we agree in this House today that it would be good if we exempted all these individuals—the 2,700 surviving patients—from any further assessment of their capacity to work?

No money could ever compensate these victims for what has happened. Their health can never be repaired, but let us ensure that as a result of this debate and of this inquiry we ensure, once and for all, that the patients do not experience further financial disadvantage from this terrible situation.